Time is slipping away from lawmakers who hope to resurrect a slate of changes to the pharmacy benefit manager (PBM) industry.

The U.S. House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of ...

This once-daily topical treatment is the latest phosphodiesterase-4 (PDE4) inhibitor designed for mild to moderate atopic ...